171
Convalescent Plasma for Early Treatment of COVID-19
Condition(s):SARS-CoV 2; COVID-19Last Updated:June 30, 2022Terminated
SARS-CoV-2: 10253 Clinical Trials, Page 18 of 1026
Hide Studies Not Open or Pending
172
The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine
Condition(s):COVID-19Last Updated:September 8, 2022Active, not recruiting
173
Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen
Condition(s):Covid19Last Updated:February 25, 2021Unknown status
174
COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation
Condition(s):SARS-CoV2 Infection; COVID-19Last Updated:October 18, 2022Completed
175
Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs
Condition(s):Covid19Last Updated:February 15, 2022Completed
176
Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults
Condition(s):Covid19Last Updated:May 17, 2022Terminated
177
Saliva as Source of Detection for SARS-CoV-2
Condition(s):COVID-19Last Updated:June 2, 2021Completed
178
Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra
Condition(s):COVID-19Last Updated:March 2, 2022Recruiting
179
A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19
Condition(s):SARS-CoV-2 Acute Respiratory DiseaseLast Updated:June 15, 2022Completed
180
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System
Condition(s):COVID-19; Healthy Volunteers; Chronic Disease; Hematological Malignancies; Solid TumorLast Updated:April 11, 2022Recruiting